Skip to Main Content

Paper Details

NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer.
Cancers (Basel)
5
2021
Author NameAffiliation
Julie E BaumanUniversity of Arizona Cancer Center, University of Arizona
Ravindra UppaluriDana Farber Cancer Institute and Brigham and Women's Hospital
  • 1 - 2

Datasets

Release 1.2